Conti DV - Search Results

1

A novel colorectal cancer risk locus at 4q32.2 identified from an international genome-wide association study.

Schmit SL, Schumacher FR, Edlund CK, Conti DV, Raskin L, Lejbkowicz F, Pinchev M, Rennert HS, Jenkins MA, Hopper JL, Buchanan DD, Lindor NM, Le Marchand L, Gallinger S, Haile RW, Newcomb PA, Huang SC, Rennert G, Casey G, Gruber SB. Schmit SL, et al. Among authors: conti dv. Carcinogenesis. 2014 Nov;35(11):2512-9. doi: 10.1093/carcin/bgu148. Epub 2014 Jul 14. Carcinogenesis. 2014. PMID: 25023989 Free PMC article.

2

Prostate cancer aggressiveness locus on chromosome 7q32-q33 identified by linkage and allelic imbalance studies.

Neville PJ, Conti DV, Paris PL, Levin H, Catalona WJ, Suarez BK, Witte JS, Casey G. Neville PJ, et al. Among authors: conti dv. Neoplasia. 2002 Sep-Oct;4(5):424-31. doi: 10.1038/sj.neo.7900254. Neoplasia. 2002. PMID: 12192601 Free PMC article.

3

Prostate cancer aggressiveness locus on chromosome segment 19q12-q13.1 identified by linkage and allelic imbalance studies.

Neville PJ, Conti DV, Krumroy LM, Catalona WJ, Suarez BK, Witte JS, Casey G. Neville PJ, et al. Among authors: conti dv. Genes Chromosomes Cancer. 2003 Apr;36(4):332-9. doi: 10.1002/gcc.10165. Genes Chromosomes Cancer. 2003. PMID: 12619157

4

CYP3A4 and CYP3A5 genotypes, haplotypes, and risk of prostate cancer.

Plummer SJ, Conti DV, Paris PL, Curran AP, Casey G, Witte JS. Plummer SJ, et al. Among authors: conti dv. Cancer Epidemiol Biomarkers Prev. 2003 Sep;12(9):928-32. Cancer Epidemiol Biomarkers Prev. 2003. PMID: 14504207

5

Comprehensive evaluation of the association between prostate cancer and genotypes/haplotypes in CYP17A1, CYP3A4, and SRD5A2.

Loukola A, Chadha M, Penn SG, Rank D, Conti DV, Thompson D, Cicek M, Love B, Bivolarevic V, Yang Q, Jiang Y, Hanzel DK, Dains K, Paris PL, Casey G, Witte JS. Loukola A, et al. Among authors: conti dv. Eur J Hum Genet. 2004 Apr;12(4):321-32. doi: 10.1038/sj.ejhg.5201101. Eur J Hum Genet. 2004. PMID: 14560315

6

DNA repair gene XRCC1 and XPD polymorphisms and risk of prostate cancer.

Rybicki BA, Conti DV, Moreira A, Cicek M, Casey G, Witte JS. Rybicki BA, et al. Among authors: conti dv. Cancer Epidemiol Biomarkers Prev. 2004 Jan;13(1):23-9. doi: 10.1158/1055-9965.epi-03-0053. Cancer Epidemiol Biomarkers Prev. 2004. PMID: 14744728

7

Comparison of missing data approaches in linkage analysis.

Xing C, Schumacher FR, Conti DV, Witte JS. Xing C, et al. Among authors: conti dv. BMC Genet. 2003 Dec 31;4 Suppl 1(Suppl 1):S44. doi: 10.1186/1471-2156-4-S1-S44. BMC Genet. 2003. PMID: 14975112 Free PMC article.

8

Association of prostate cancer risk and aggressiveness to androgen pathway genes: SRD5A2, CYP17, and the AR.

Cicek MS, Conti DV, Curran A, Neville PJ, Paris PL, Casey G, Witte JS. Cicek MS, et al. Among authors: conti dv. Prostate. 2004 Apr 1;59(1):69-76. doi: 10.1002/pros.10358. Prostate. 2004. PMID: 14991867

9

Relationship between methylenetetrahydrofolate reductase C677T and A1298C genotypes and haplotypes and prostate cancer risk and aggressiveness.

Cicek MS, Nock NL, Li L, Conti DV, Casey G, Witte JS. Cicek MS, et al. Among authors: conti dv. Cancer Epidemiol Biomarkers Prev. 2004 Aug;13(8):1331-6. Cancer Epidemiol Biomarkers Prev. 2004. PMID: 15298954

10

XRCC1, XRCC3, and XPD polymorphisms as modifiers of the effect of smoking and alcohol on colorectal adenoma risk.

Stern MC, Siegmund KD, Conti DV, Corral R, Haile RW. Stern MC, et al. Among authors: conti dv. Cancer Epidemiol Biomarkers Prev. 2006 Dec;15(12):2384-90. doi: 10.1158/1055-9965.EPI-06-0381. Cancer Epidemiol Biomarkers Prev. 2006. PMID: 17164360

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

365 results

Search Page